• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于潜在鼻脑递送的聚己内酯-艾地苯醌纳米颗粒的合成与表征

Synthesis and Characterization of PCL-Idebenone Nanoparticles for Potential Nose-to-Brain Delivery.

作者信息

Boyuklieva Radka, Hristozova Asya, Pilicheva Bissera

机构信息

Department of Pharmaceutical Sciences, Faculty of Pharmacy, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria.

Research Institute, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria.

出版信息

Biomedicines. 2023 May 22;11(5):1491. doi: 10.3390/biomedicines11051491.

DOI:10.3390/biomedicines11051491
PMID:37239161
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10216815/
Abstract

The present work is focused on the preparation of an optimal model of poly-ε-caprolactone nanoparticles as potential carriers for nasal administration of idebenone. A solvent/evaporation technique was used for nanoparticle preparation. Poly-ε-caprolactone with different molecular weights (14,000 and 80,000 g/mol) was used. Polysorbate 20 and Poloxamer 407, alone and in combination, were used as emulsifiers at different concentrations to obtain a stable formulation. The nanoparticles were characterized using dynamic light scattering, SEM, TEM, and FTIR. The resulting structures were spherical in shape and their size distribution depended on the type of emulsifier. The average particle size ranged from 188 to 628 nm. The effect of molecular weight and type of emulsifier was established. Optimal models of appropriate size for nasal administration were selected for inclusion of idebenone. Three models of idebenone-loaded nanoparticles were developed and the effect of molecular weight on the encapsulation efficiency was investigated. Increased encapsulation efficiency was found when poly-ε-caprolactone with lower molecular weight was used. The molecular weight also affected the drug release from the nanostructures. Dissolution study data were fitted into various kinetic models and the Korsmeyer-Peppas model was found to be indicative of the release mechanism of idebenone.

摘要

本研究聚焦于制备聚己内酯纳米颗粒的优化模型,作为艾地苯醌鼻腔给药的潜在载体。采用溶剂蒸发技术制备纳米颗粒。使用了不同分子量(14,000和80,000 g/mol)的聚己内酯。聚山梨酯20和泊洛沙姆407单独或组合使用,以不同浓度作为乳化剂来获得稳定的制剂。使用动态光散射、扫描电子显微镜、透射电子显微镜和傅里叶变换红外光谱对纳米颗粒进行表征。所得结构呈球形,其尺寸分布取决于乳化剂的类型。平均粒径范围为188至628 nm。确定了分子量和乳化剂类型的影响。选择适合鼻腔给药的合适尺寸的优化模型以包载艾地苯醌。开发了三种载艾地苯醌纳米颗粒模型,并研究了分子量对包封率的影响。发现使用较低分子量的聚己内酯时包封率增加。分子量也影响药物从纳米结构中的释放。将溶出研究数据拟合到各种动力学模型中,发现Korsmeyer-Peppas模型可指示艾地苯醌的释放机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f3a/10216815/a88b11936427/biomedicines-11-01491-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f3a/10216815/06a6737eb993/biomedicines-11-01491-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f3a/10216815/9ba3ff86eda1/biomedicines-11-01491-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f3a/10216815/ffca7e2a3dd1/biomedicines-11-01491-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f3a/10216815/c2ce04ef74ed/biomedicines-11-01491-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f3a/10216815/11bf37275cd3/biomedicines-11-01491-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f3a/10216815/186d4d8f6c31/biomedicines-11-01491-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f3a/10216815/a88b11936427/biomedicines-11-01491-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f3a/10216815/06a6737eb993/biomedicines-11-01491-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f3a/10216815/9ba3ff86eda1/biomedicines-11-01491-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f3a/10216815/ffca7e2a3dd1/biomedicines-11-01491-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f3a/10216815/c2ce04ef74ed/biomedicines-11-01491-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f3a/10216815/11bf37275cd3/biomedicines-11-01491-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f3a/10216815/186d4d8f6c31/biomedicines-11-01491-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f3a/10216815/a88b11936427/biomedicines-11-01491-g007.jpg

相似文献

1
Synthesis and Characterization of PCL-Idebenone Nanoparticles for Potential Nose-to-Brain Delivery.用于潜在鼻脑递送的聚己内酯-艾地苯醌纳米颗粒的合成与表征
Biomedicines. 2023 May 22;11(5):1491. doi: 10.3390/biomedicines11051491.
2
Structure and Fate of Nanoparticles Designed for the Nasal Delivery of Poorly Soluble Drugs.用于鼻腔递送难溶性药物的纳米粒子的结构和命运。
Mol Pharm. 2021 Aug 2;18(8):3132-3146. doi: 10.1021/acs.molpharmaceut.1c00366. Epub 2021 Jul 14.
3
Poly(ε-caprolactone), Eudragit® RS 100 and poly(ε-caprolactone)/Eudragit® RS 100 blend submicron particles for the sustained release of the antiretroviral efavirenz.聚(ε-己内酯)、Eudragit® RS 100 以及聚(ε-己内酯)/Eudragit® RS 100 共混亚微粒子用于持续释放抗逆转录病毒药物依非韦伦。
Colloids Surf B Biointerfaces. 2013 Feb 1;102:441-9. doi: 10.1016/j.colsurfb.2012.06.038. Epub 2012 Aug 17.
4
Design, development, and characterization of an idebenone-loaded poly-ε-caprolactone intravitreal implant as a new therapeutic approach for LHON treatment.设计、开发和表征载依地酸二钠的聚己内酯眼内植入物,作为 LHON 治疗的新治疗方法。
Eur J Pharm Biopharm. 2021 Nov;168:195-207. doi: 10.1016/j.ejpb.2021.09.001. Epub 2021 Sep 7.
5
Synthesis, characterization, and evaluation of chloroaluminium phthalocyanine incorporated in poly(ε-caprolactone) nanoparticles for photodynamic therapy.合成、表征及聚己内酯纳米粒子中氯代铝酞菁的光动力疗法评价。
Photodiagnosis Photodyn Ther. 2022 Jun;38:102850. doi: 10.1016/j.pdpdt.2022.102850. Epub 2022 Apr 5.
6
Formulation and Evaluation of Atorvastatin Calcium-Poly-ε-Caprolactone Nanoparticles Loaded Ocular Inserts for Sustained Release and Antiinflammatory Efficacy.阿托伐他汀钙-聚己内酯纳米载体制备及载药眼用植入剂的评价-缓释及抗炎效果。
Curr Pharm Biotechnol. 2020;21(15):1688-1698. doi: 10.2174/1389201021666200519133350.
7
Poly(epsilon-caprolactone)/poly(ethylene glycol)/poly(epsilon-caprolactone) nanoparticles: preparation, characterization, and application in doxorubicin delivery.聚己内酯/聚乙二醇/聚己内酯纳米粒的制备、表征及其在阿霉素传递中的应用。
J Phys Chem B. 2009 Oct 1;113(39):12928-33. doi: 10.1021/jp905781g.
8
Poly(3-hydroxybutyrate-co-epsilon-caprolactone) copolymers and poly(3-hydroxybutyrate-co-3-hydroxyvalerate-co-epsilon-caprolactone) terpolymers as novel materials for colloidal drug delivery systems.聚(3-羟基丁酸酯-共-ε-己内酯)共聚物和聚(3-羟基丁酸酯-共-3-羟基戊酸酯-共-ε-己内酯)三元共聚物作为用于胶体药物递送系统的新型材料。
Eur J Pharm Sci. 2009 Jun 28;37(3-4):451-62. doi: 10.1016/j.ejps.2009.03.017.
9
Synthesis, self-assembly, and in vitro doxorubicin release behavior of dendron-like/linear/dendron-like poly(epsilon-caprolactone)-b-poly(ethylene glycol)-b-poly(epsilon-caprolactone) triblock copolymers.树枝状/线性/树枝状聚(ε-己内酯)-b-聚(乙二醇)-b-聚(ε-己内酯)三嵌段共聚物的合成、自组装及阿霉素体外释放行为
Biomacromolecules. 2009 Aug 10;10(8):2310-8. doi: 10.1021/bm900497z.
10
Oridonin-loaded poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon-caprolactone) copolymer nanoparticles: preparation, characterization, and antitumor activity on mice with transplanted hepatoma.载有冬凌草甲素的聚(ε-己内酯)-聚(环氧乙烷)-聚(ε-己内酯)共聚物纳米粒:制备、表征及其对移植性肝癌小鼠的抗肿瘤活性
J Drug Target. 2008 Jul;16(6):479-85. doi: 10.1080/10611860802200938.

引用本文的文献

1
3D-Printable Photothermal and Temperature-Controlled Polycaprolactone Scaffolds Incorporating Gold Plasmonic Blackbodies for Bone Tissue Engineering.用于骨组织工程的、包含金等离子体黑体的3D可打印光热和温度可控聚己内酯支架
ACS Appl Mater Interfaces. 2025 May 21;17(20):29455-29468. doi: 10.1021/acsami.5c05707. Epub 2025 May 12.

本文引用的文献

1
Naturally Occurring Antioxidant Therapy in Alzheimer's Disease.阿尔茨海默病的天然抗氧化剂疗法
Antioxidants (Basel). 2022 Jan 23;11(2):213. doi: 10.3390/antiox11020213.
2
Effectiveness of idebenone nanorod formulations in the treatment of Alzheimer's disease.艾地苯醌纳米棒制剂治疗阿尔茨海默病的疗效。
J Control Release. 2021 Aug 10;336:169-180. doi: 10.1016/j.jconrel.2021.06.024. Epub 2021 Jun 22.
3
Idebenone: When an antioxidant is not an antioxidant.依地酸二钠:抗氧化剂非抗氧化剂。
Redox Biol. 2021 Jan;38:101812. doi: 10.1016/j.redox.2020.101812. Epub 2020 Nov 25.
4
Nanotechnology: A Promising Approach for Delivery of Neuroprotective Drugs.纳米技术:一种递送神经保护药物的有前景的方法。
Front Neurosci. 2020 Jun 9;14:494. doi: 10.3389/fnins.2020.00494. eCollection 2020.
5
Idebenone Protects against Atherosclerosis in Apolipoprotein E-Deficient Mice Via Activation of the SIRT3-SOD2-mtROS Pathway.依地苯醌通过激活 SIRT3-SOD2-mtROS 通路防治载脂蛋白 E 缺陷小鼠动脉粥样硬化。
Cardiovasc Drugs Ther. 2021 Dec;35(6):1129-1145. doi: 10.1007/s10557-020-07018-5.
6
Idebenone attenuates cerebral inflammatory injury in ischemia and reperfusion via dampening NLRP3 inflammasome activity.依达拉奉通过抑制 NLRP3 炎性小体活性减轻脑缺血再灌注后的炎症损伤。
Mol Immunol. 2020 Jul;123:74-87. doi: 10.1016/j.molimm.2020.04.013. Epub 2020 May 18.
7
Physicochemical Characterization and Antioxidant Activity Evaluation of Idebenone/Hydroxypropyl--Cyclodextrin Inclusion Complex †.艾地苯/羟丙基-β-环糊精包合物的理化性质表征及抗氧化活性评价。
Biomolecules. 2019 Sep 25;9(10):531. doi: 10.3390/biom9100531.
8
Idebenone Alleviates Neuroinflammation and Modulates Microglial Polarization in LPS-Stimulated BV2 Cells and MPTP-Induced Parkinson's Disease Mice.艾地苯醌减轻脂多糖刺激的BV2细胞和1-甲基-4-苯基-1,2,3,6-四氢吡啶诱导的帕金森病小鼠的神经炎症并调节小胶质细胞极化。
Front Cell Neurosci. 2019 Jan 9;12:529. doi: 10.3389/fncel.2018.00529. eCollection 2018.
9
Quercetin and Idebenone Ameliorate Oxidative Stress, Inflammation, DNA damage, and Apoptosis Induced by Titanium Dioxide Nanoparticles in Rat Liver.槲皮素和艾地苯醌改善二氧化钛纳米颗粒诱导的大鼠肝脏氧化应激、炎症、DNA损伤及细胞凋亡。
Dose Response. 2018 Dec 9;16(4):1559325818812188. doi: 10.1177/1559325818812188. eCollection 2018 Oct-Dec.
10
Connection between Systemic Inflammation and Neuroinflammation Underlies Neuroprotective Mechanism of Several Phytochemicals in Neurodegenerative Diseases.系统性炎症与神经炎症之间的联系是几种植物化学物质在神经退行性疾病中神经保护机制的基础。
Oxid Med Cell Longev. 2018 Oct 8;2018:1972714. doi: 10.1155/2018/1972714. eCollection 2018.